AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹1.30 Cr | ₹-5.88 Cr | ₹0.65 Cr | ₹-1.97 Cr | ₹-2.64 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹1.30 Cr |
| Mar2025 | ₹-5.88 Cr |
| Mar2024 | ₹0.65 Cr |
| Mar2023 | ₹-1.97 Cr |
| Mar2022 | ₹-2.64 Cr |
How is Net Cash Inflow / Outflow of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.30 Cr | Positive | |
| Mar2025 | ₹-5.88 Cr | Negative | |
| Mar2024 | ₹0.65 Cr | Positive | |
| Mar2023 | ₹-1.97 Cr | Negative | |
| Mar2022 | ₹-2.64 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹316.2 Cr | 2.3% | 42.7% | 42.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | 2.3% |
42.7% |
42.3% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses